U.S. Interventional Cardiology And Peripheral Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Interventional Catheters, Microcatheters, Peripheral Stents), By Application, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Application
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Application outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Interventional Cardiology and Peripheral Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. U.S. Interventional Cardiology and Peripheral Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Interventional Cardiology and Peripheral Market: Product Estimates & Trend Analysis
                    4.1. Product Segment Dashboard
                    4.2. U.S. Interventional Cardiology and Peripheral Market: Product Movement Analysis
                    4.3. U.S. Interventional Cardiology and Peripheral Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    4.4. Interventional Catheters
                        4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.5. Microcatheters
                        4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.5.2. Support Microcatheters
                            4.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.5.3. Delivery Microcatheters
                            4.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.5.4. Others
                            4.5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.6. Guidewires
                        4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.7. Peripheral Stents
                        4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.7.2. Self-Expanding
                            4.7.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.7.3. Balloon-Expandable
                            4.7.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.7.4. Drug-Eluting Stents
                            4.7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.8. Coronary Stents
                        4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.8.2. Bioabsorbable Stents
                            4.8.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.8.3. Drug-Eluting Stents
                            4.8.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.8.4. Bare Metal Stents
                            4.8.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.9. PTCA Balloon Catheters
                        4.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.10. Atherectomy Devices
                        4.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.11. Chronic Total Occlusion Devices
                        4.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.12. Synthetic Surgical Grafts
                        4.12.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.13. Embolic Protection Devices
                        4.13.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.14. IVC Filters
                        4.14.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.15. PTA Balloon Catheters
                        4.15.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.16. Thrombectomy Devices
                        4.16.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Interventional Cardiology and Peripheral Market: Application Estimates & Trend Analysis
                    5.1. Application Segment Dashboard
                    5.2. U.S. Interventional Cardiology and Peripheral Market: Application Movement Analysis
                    5.3. U.S. Interventional Cardiology and Peripheral Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    5.4. Angioplasty
                        5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.5. Congenital Heart Defect Correction
                        5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.6. Thrombectomy
                        5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.7. Valvuloplasty
                        5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.8. Percutaneous Valve Repair
                        5.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.9. Others
                        5.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. Key company heat map analysis, 2024
                    6.4. Company Profiles
                        6.4.1. B. Braun SE
                            6.4.1.1. Company overview
                            6.4.1.2. Financial performance
                            6.4.1.3. Product benchmarking
                            6.4.1.4. Strategic initiatives
                        6.4.2. BD
                            6.4.2.1. Company overview
                            6.4.2.2. Financial performance
                            6.4.2.3. Product benchmarking
                            6.4.2.4. Strategic initiatives
                        6.4.3. Cardinal Health
                            6.4.3.1. Company overview
                            6.4.3.2. Financial performance
                            6.4.3.3. Product benchmarking
                            6.4.3.4. Strategic initiatives
                        6.4.4. Medtronic
                            6.4.4.1. Company overview
                            6.4.4.2. Financial performance
                            6.4.4.3. Product benchmarking
                            6.4.4.4. Strategic initiatives
                        6.4.5. Teleflex Incorporated
                            6.4.5.1. Company overview
                            6.4.5.2. Financial performance
                            6.4.5.3. Product benchmarking
                            6.4.5.4. Strategic initiatives
                        6.4.6. W. L. Gore & Associates Inc.
                            6.4.6.1. Company overview
                            6.4.6.2. Financial performance
                            6.4.6.3. Product benchmarking
                            6.4.6.4. Strategic initiatives
                        6.4.7. Cook
                            6.4.7.1. Company overview
                            6.4.7.2. Financial performance
                            6.4.7.3. Product benchmarking
                            6.4.7.4. Strategic initiatives
                        6.4.8. Boston Scientific Corporation
                            6.4.8.1. Company overview
                            6.4.8.2. Financial performance
                            6.4.8.3. Product benchmarking
                            6.4.8.4. Strategic initiatives
                        6.4.9. AngioDynamics
                            6.4.9.1. Company overview
                            6.4.9.2. Financial performance
                            6.4.9.3. Product benchmarking
                            6.4.9.4. Strategic initiatives
                        6.4.10. Abbott
                            6.4.10.1. Company overview
                            6.4.10.2. Financial performance
                            6.4.10.3. Product benchmarking
                            6.4.10.4. Strategic initiatives
                        6.4.11. OrbusNeich Medical Group Holdings Limited
                            6.4.11.1. Company overview
                            6.4.11.2. Financial performance
                            6.4.11.3. Product benchmarking
                            6.4.11.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. interventional cardiology and peripheral market, by country (USD Million) 2021 - 2033
Table 3 U.S. interventional cardiology and peripheral market, by product (USD Million) 2021 - 2033
Table 4 U.S. interventional cardiology and peripheral market, by application (USD Million) 2021 - 2033

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. interventional cardiology and peripheral market: market outlook
Fig. 10 U.S. interventional cardiology and peripheral competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. interventional cardiology and peripheral market driver impact
Fig. 16 U.S. interventional cardiology and peripheral market restraint impact
Fig. 17 U.S. interventional cardiology and peripheral market strategic initiatives analysis
Fig. 18 U.S. interventional cardiology and peripheral market: Product movement analysis
Fig. 19 U.S. interventional cardiology and peripheral market: Product outlook and key takeaways
Fig. 20 Interventional catheters estimates and forecast, 2021 - 2033
Fig. 21 Microcatheters estimates and forecast, 2021 - 2033
Fig. 22 Support microcatheters estimates and forecast, 2021 - 2033
Fig. 23 Delivery microcatheters estimates and forecast, 2021 - 2033
Fig. 24 Other estimates and forecasts, 2021 - 2033
Fig. 25 Guidewires estimates and forecast, 2021 - 2033
Fig. 26 Peripheral stents estimates and forecast, 2021 - 2033
Fig. 27 Self-expanding estimates and forecast, 2021 - 2033
Fig. 28 Balloon-expandable estimates and forecast, 2021 - 2033
Fig. 29 Drug-eluting stents estimates and forecast, 2021 - 2033
Fig. 30 Coronary stents estimates and forecast, 2021 - 2033
Fig. 31 Bioabsorbable stents estimates and forecast, 2021 - 2033
Fig. 32 Drug-eluting stents estimates and forecast, 2021 - 2033
Fig. 33 Bare metal stents estimates and forecast, 2021 - 2033
Fig. 34 PTCA balloon catheters estimates and forecast, 2021 - 2033
Fig. 35 Atherectomy devices estimates and forecast, 2021 - 2033
Fig. 36 Chronic total occlusion devices estimates and forecast, 2021 - 2033
Fig. 37 Synthetic surgical grafts estimates and forecast, 2021 - 2033
Fig. 38 Embolic protection devices estimates and forecast, 2021 - 2033
Fig. 39 IVC filters estimates and forecast, 2021 - 2033
Fig. 40 PTA balloon catheters estimates and forecast, 2021 - 2033
Fig. 41 Thrombectomy devices estimates and forecast, 2021 - 2033
Fig. 42 U.S. interventional cardiology and peripheral market: Application movement analysis
Fig. 43 U.S. interventional cardiology and peripheral market: Application outlook and key takeaways
Fig. 44 Angioplasty estimates and forecast, 2021 - 2033
Fig. 45 Congenital heart defect correction estimates and forecast, 2021 - 2033
Fig. 46 Thrombectomy estimates and forecast, 2021 - 2033
Fig. 47 Valvuloplasty estimates and forecast, 2021 - 2033
Fig. 48 Percutaneous valve repair estimates and forecast, 2021 - 2033
Fig. 49 Other estimates and forecasts, 2021 - 2033